High risk cytogenetic abnormalities in patients with multiple myeloma Características citogenéticas y detección de anormalidades de alto riesgo en mieloma múltiple
Author
dc.contributor.author
Legües, María Eugenia
Author
dc.contributor.author
Morales, Paulina
Author
dc.contributor.author
Valenzuela, Mercedes
Author
dc.contributor.author
Encina, Andrea
Author
dc.contributor.author
Martí, María José
Author
dc.contributor.author
Bascuñán, Claudia
Author
dc.contributor.author
Cornejo, Paulina
Author
dc.contributor.author
Peña, Camila
Author
dc.contributor.author
Undurraga, María Soledad
Admission date
dc.date.accessioned
2019-10-15T12:25:34Z
Available date
dc.date.available
2019-10-15T12:25:34Z
Publication date
dc.date.issued
2019
Cita de ítem
dc.identifier.citation
Revista Medica de Chile, Volumen 147, Issue 1, 2019, Pages 61-64
Identifier
dc.identifier.issn
07176163
Identifier
dc.identifier.issn
00349887
Identifier
dc.identifier.other
10.4067/S0034-98872019000100061
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/171727
Abstract
dc.description.abstract
Background: Cytogenetic abnormalities observed in the bone marrow of patients with multiple myeloma (MM) are an important prognostic factor for risk stratification. Aim: To investigate karyotype characteristics and frequency of the high-risk cytogenetic abnormalities t(4;14), t(14;16) and del(17p) in Chilean patients with MM. Material and Methods: We studied 30 patients with MM by conventional cytogenetics (CC) and fluorescent in situ hybridization of plasma cells selected using cytoplasmic immunoglobulin staining (cIg-FISH). Results: Overall, the two techniques in combination allowed us to identify clonal genetic abnormalities in 47% of patients. The t(4;14) abnormality was observed in 19% of patients, del(17p) was observed in 10% of patients, and t(14;16) was not detected. Conclusions: Our results showed frequencies of high-risk abnormalities similar to those reported abroad. Cytogenetic studies should be performed routinely f
High risk cytogenetic abnormalities in patients with multiple myeloma Características citogenéticas y detección de anormalidades de alto riesgo en mieloma múltiple